InvestorsHub Logo
Followers 37
Posts 6017
Boards Moderated 1
Alias Born 08/07/2018

Re: uglypug post# 116884

Saturday, 09/07/2019 9:01:06 AM

Saturday, September 07, 2019 9:01:06 AM

Post# of 163975


Great post pug. It seems pretty clear to me that with over 30,000 application for Vytex the most obvious cost efficient and effective way to fully market and monetize Vytex is with licensing deals. No upfront costs, or risks,
just sit back and collect royalties. Remember " Intel inside " ? Think " Vytex inside ". Vystar then can use these revenues to consolidate resources, further R&D and GROW the business. It seem clear to me that this is the approach that Steve Rotman & company are taking with their business plan.


Vystar Corporation
@VystarCompany
·
Aug 30
Replying to
@jcmeyer72
and
@BakerKeto
We are focused on one large Pharmaceutical Partner who can deal with the FDA... We will just provide the technology as a license with royalties to avoid any litigation issues that may arise. $VYST


Vystar Corporation
@VystarCompany
·
Aug 30
Replying to
@MTLTrader2
Everyone who buys Vytex pays some form (or should be) of royalty. This can be from CentroTrade (Now HalyconAgri) or by way of a finished product like Vytex Foam. $VYST


VYST




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News